No Data
No Data
Here's Why We Think Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Looks Fair for the Time Being
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
12 Health Care Stocks Moving In Friday's Intraday Session
Here's Why We're Not Too Worried About Immatics' (NASDAQ:IMTX) Cash Burn Situation
Immatics Is Maintained at Buy by Mizuho
Mizuho Bank: Maintaining the Immatics (IMTX.US) rating, adjusted from buy to buy rating, and adjusted the target price from $14.00 to $16.00.
Mizuho Bank: Maintaining the Immatics (IMTX.US) rating, adjusted from buy to buy rating, and adjusted the target price from $14.00 to $16.00.